Insider · CIK 0001578770

D'Onofrio Matthew J

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001578770

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−64.8K sh	—	—	0
2025-12-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−70K sh	—	—	0
2025-12-16	EVOKEvoke Pharma IncU Disposition from Tender	Director, Chief Executive Officer	UDisposition from Tender	−15.5K sh	—	—	0
2025-03-21	EVOKEvoke Pharma IncA Award	Director, Chief Executive Officer	AAward	+1,000 sh	$2.80	+$2,797.2	9,820
2025-02-28	EVOKEvoke Pharma IncA Award	Director, Chief Executive Officer	AAward	+6,849 sh	$3.65	+$25K	8,820
2025-01-28	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+70K sh	—	—	70,000
2024-08-07	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+64.8K sh	—	—	64,840
2023-02-08	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+25K sh	—	—	25,000
2022-02-02	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2021-01-27	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	300,000
2020-12-11	EVOKEvoke Pharma IncS Sale	Director, Chief Executive Officer	SSale	−40.4K sh	$2.91	−$117K	283,997
2020-12-10	EVOKEvoke Pharma IncS Sale	Director, Chief Executive Officer	SSale	−5,643 sh	$2.95	−$16.6K	324,354
2020-12-09	EVOKEvoke Pharma IncM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+46K sh	$0.40	+$18.4K	329,997
2020-12-09	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−46K sh	—	—	0
2020-09-01	EVOKEvoke Pharma IncJ Other	Director, Chief Executive Officer	JOther	+20.2K sh	$1.05	+$21.2K	283,997
2020-03-02	EVOKEvoke Pharma IncA Award	Director, Chief Executive Officer	AAward	+25K sh	$0.85	+$21.3K	263,759
2020-02-28	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	200,000
2019-06-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	−53K sh	—	—	53,015
2019-06-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	+65K sh	—	—	0
2019-06-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	+70.7K sh	—	—	0
2019-06-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	+52.5K sh	—	—	0
2019-06-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	+150K sh	—	—	0
2019-06-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	+150K sh	—	—	0
2019-06-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	+150K sh	—	—	0
2019-06-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	−48.8K sh	—	—	48,750
2019-06-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	−39.4K sh	—	—	39,375
2019-06-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	−113K sh	—	—	112,500
2019-06-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	−113K sh	—	—	112,500
2019-06-17	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	−113K sh	—	—	112,500
2019-02-06	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	150,000
2018-08-31	EVOKEvoke Pharma IncJ Other	Director, Chief Executive Officer	JOther	+13K sh	$1.63	+$21.2K	238,759
2018-04-26	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	150,000
2017-08-31	EVOKEvoke Pharma IncJ Other	Director, Chief Executive Officer	JOther	+1,115 sh	$2.15	+$2,397.25	225,723
2017-02-28	EVOKEvoke Pharma IncJ Other	Director, Chief Executive Officer	JOther	+12K sh	$1.60	+$19.2K	224,608
2017-01-25	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+150K sh	—	—	150,000
2016-03-01	EVOKEvoke Pharma IncJ Other	Director, Chief Executive Officer	JOther	+10.9K sh	$2.90	+$31.7K	212,608
2016-02-05	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+52.5K sh	—	—	52,500
2016-02-05	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+70.7K sh	—	—	70,687
2016-02-05	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−94.3K sh	—	—	0
2016-02-05	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−70K sh	—	—	0
2016-01-28	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+65K sh	—	—	65,000
2015-03-06	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+70K sh	—	—	70,000
2015-02-27	EVOKEvoke Pharma IncJ Other	Director, Chief Executive Officer	JOther	+6,671 sh	$4.75	+$31.7K	201,671
2013-12-02	EVOKEvoke Pharma Inc · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+94.3K sh	—	—	94,250

Recent filings

Accepted (ET)
Dec 174
D'Onofrio Matthew J0001193125-25-322637
SEC(opens sec.gov)
Mar 244
D'Onofrio Matthew J0000950170-25-043893
SEC(opens sec.gov)
Mar 34
D'Onofrio Matthew J0000950170-25-030904
SEC(opens sec.gov)
Jan 294
D'Onofrio Matthew J0000950170-25-010535
SEC(opens sec.gov)
Aug 84
D'Onofrio Matthew J0000950170-24-094132
SEC(opens sec.gov)
Feb 104
D'Onofrio Matthew J0001209191-23-008328
SEC(opens sec.gov)
Feb 44
D'Onofrio Matthew J0001209191-22-007263
SEC(opens sec.gov)
Jan 294
D'Onofrio Matthew J0001209191-21-006082
SEC(opens sec.gov)
Dec 144
D'Onofrio Matthew J0001209191-20-063364
SEC(opens sec.gov)
Dec 114
D'Onofrio Matthew J0001209191-20-063098
SEC(opens sec.gov)
Sep 24
D'Onofrio Matthew J0001209191-20-049014
SEC(opens sec.gov)
Mar 34
D'Onofrio Matthew J0001209191-20-015803
SEC(opens sec.gov)
Jun 194
D'Onofrio Matthew J0001209191-19-038034
SEC(opens sec.gov)

Companies

Evoke Pharma IncDirector, Chief Executive OfficerEVOK

Address

C/O EVOKE PHARMA, INC. 12555 HIGH BLUFF DRIVE, SUITE 385

SAN DIEGO, CA, 92130